help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukayama, S.
Right arrow Articles by Tashjian, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukayama, S.
Right arrow Articles by Tashjian, A. H., Jr

Endocrinology, Vol 125, 1789-1794, Copyright © 1989 by Endocrine Society


ARTICLES

Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein

S Fukayama and AH Tashjian Jr
Laboratory of Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.

We have reported previously that 17 beta-estradiol (E2) inhibits selectively the cAMP response to human (h) PTH and PTH-related protein (hPTHrP), but not to vasoactive intestinal peptide, in human osteoblast- like cells (SaOS-2). We have now extended these studies to investigate the actions of androgens on hPTH-stimulated accumulation of cAMP, and on the roles of new protein synthesis and pertussis toxin (PTox) substrates in the actions of steroid hormones on SaOS-2 cells. Pretreatment with testosterone (T) or 5 alpha-dihydrotestosterone (5 alpha-DHT) for 4-12 h at concentrations of 10(-12) to 10(-8) M inhibited significantly the cAMP response to hPTH by up to 50-70% of control. Like E2, the actions of T and 5 alpha-DHT were selective for hPTH or hPTHrP; there was no inhibition of the stimulatory action of vasoactive intestinal peptide. Two related steroids, 5 beta-DHT and 17 alpha-epitestosterone, did not inhibit the action of hPTH. Pretreatment of cells with cycloheximide, under conditions which inhibited protein synthesis by greater than 90%, reduced the cAMP response to hPTH but did not block the further inhibitory actions of E2, T, or 5 alpha-DHT. Pretreamtent of cells with PTox (100 ng/ml) for 24 h, enhanced the accumulation of cAMP stimulated by hPTH consistent with an action of PTox on Gi; however, the inhibitory actions of E2, T, and 5 alpha-DHT on PTH-stimulated cAMP accumulation were not attenuated by PTox. We conclude that androgens, as well as estrogens, act directly on human bone cells to modulate selectively an early effect of hPTH. The inhibitory actions of these steroid hormones do not appear to depend on new protein synthesis and may not involve a functionally active PTox substrate, presumably Gi.


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Homme, C. P. Schmitt, R. Himmele, G. F. Hoffmann, O. Mehls, and F. Schaefer
Vitamin D and Dexamethasone Inversely Regulate Parathyroid Hormone-Induced Regulator of G Protein Signaling-2 Expression in Osteoblast-Like Cells
Endocrinology, June 1, 2003; 144(6): 2496 - 2504.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. B. Jonsson, M. R. John, R. C. Gensure, T. J. Gardella, and H. Juppner
Tuberoinfundibular Peptide 39 Binds to the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor, but Functions as an Antagonist
Endocrinology, February 1, 2001; 142(2): 704 - 709.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. E. Compston
Sex Steroids and Bone
Physiol Rev, January 1, 2001; 81(1): 419 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. V. Zborowski, J. A. Cauley, E. O. Talbott, D. S. Guzick, and S. J. Winters
Bone Mineral Density, Androgens, and the Polycystic Ovary: The Complex and Controversial Issue of Androgenic Influence in Female Bone
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3496 - 3506.
[Full Text]


Home page
EndocrinologyHome page
K. Wiren, E. Keenan, X. Zhang, B. Ramsey, and E. Orwoll
Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness
Endocrinology, July 1, 1999; 140(7): 3114 - 3124.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Palmer, J.-P. Bonjour, and J. Caverzasio
Expression of a Newly Identified Phosphate Transporter/Retrovirus Receptor in Human SaOS-2 Osteoblast-Like Cells and Its Regulation by Insulin-Like Growth Factor I
Endocrinology, December 1, 1997; 138(12): 5202 - 5209.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. O. Abu, A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston
The Localization of Androgen Receptors in Human Bone
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3493 - 3497.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Vered, I. Kaiserman, B.-A. Sela, and J. Sack
Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 576 - 578.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society